03.01.24 -- New DSCSA Guidance Details Layers Of Verification System Requirements

Anticyclical by tradition, the pharmaceutical industry is one of the sectors that copes best with the difficulties caused by the pandemic. Learn about the growing market, emerging challenges, and more.

Here are the factors that are driving blister to the forefront of pharmaceutical packaging, and at an even faster rate than its current growth.

Drug development is a long and complex process, and every step has specific goals. Explore the relevant objectives and techniques used in each stage of antibody drug development.

By transitioning to alternative solvents or leveraging process aids, the challenges associated with the use of these chemicals can be addressed, helping create a sustainable, greener footprint.

Multicomponent filling and sterilizing systems represent unique advantages for vaccine production. Learn how B/F/S systems can be adapted for vaccine production without incurring any product degradation.

A partnership between Cytiva and Teva Pharmaceuticals showcases tech transfer success through effective communication, diligent project management, and a wide range of expertise.

To meet immediate vaccine demand, aseptic manufacturing capacity must increase quickly. This means environmental monitoring programs must adapt rapidly as well. Thoughtful planning can help.

Explore some of the more challenging aspects surrounding in-use testing for parenteral delivery along with potential strategies to address these issues.

The heterogeneity of a biologic product has implications for the safety and efficacy of the final therapy. Gain insight into the challenges associated with charged variants, including mAbs and fusion proteins.